Apellis Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Apellis Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Apellis Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $16.3M, a 2.42% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $16.3M -$405K -2.42% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $15M -$2.86M -16% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $16.7M -$2M -10.7% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $15.5M -$4.04M -20.7% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $16.7M -$4.03M -19.4% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 $17.9M -$2.12M -10.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $18.7M -$1.15M -5.8% Dec 31, 2022 10-K/A 2024-02-29
Q3 2022 $19.5M -$1.41M -6.73% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $20.8M -$1.18M -5.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $20M -$2.55M -11.3% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $19.9M +$2.18M +12.3% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $20.9M +$2.39M +12.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $21.9M +$8.98M +69.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $22.5M +$8.8M +64.2% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $17.7M +$3.61M +25.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $18.5M +$5.21M +39.1% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $13M +$6.36M +96.3% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $13.7M +$7.12M +108% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $14.1M +$8.6M +156% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $13.3M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $6.6M Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $6.6M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $5.51M Jan 1, 2019 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.